BREAST CANCER
March 28, 2023
Examining Bevacizumab Use and Associated Adverse Events
March 28, 2023
Racial Disparities in BC Associated With Poorer Outcomes
March 28, 2023
HER2-Low BC Incidence, Clinical Features, and Outcomes
March 6, 2023
BC Risk in Transgender Women on Hormonal Therapy
January 10, 2023
Adverse Effects of PD-1, PD-L1 Inhibitors in TNBC
January 10, 2023
Drug-Drug Interactions With Endocrine Therapy in BC Patients
December 13, 2022
Sequential Treatment Regimen Costs for MBC
December 13, 2022
Tamoxifen Increases Risk of Endometrial, Uterine Cancers
December 13, 2022
Limitations of Pathologic Complete Response as Surrogate Marker
November 9, 2022
Multicenter Study of CDK4/6 Inhibitors in Male BC
Copyright © 2000 - 2023 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.